Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.
Neuroscience and Biobehavioral Reviews June 1, 2025 Shakila Meshkat, Gunjan Malik, Richard J. Zeifman et al. 11 citations
Psilocybin, a serotonergic psychedelic, may have therapeutic benefits for Substance Use Disorders (SUDs), but its overall efficacy and safety remain uncertain. This systematic review assessed the safety and efficacy of psilocybin for SUDs through a systematic database search conducted via OVID on May 22, 2024, and summarized 26 ongoing clinical trials registered on clinicaltrials.gov. Among 16...